Breast cancer screening delays affect 8 million women in US

More than 8 million American women aged 45 to 64 are currently overdue for breast cancer screenings. This delay in detection is significant given that breast cancer is expected to cause over 40,000 deaths in the United States this year.

Barriers to timely screening include government regulations and insurance administrative requirements. Specifically, insurers such as UnitedHealthcare and Cigna utilize processes like prior authorization and precertification for breast MRIs and outpatient imaging, which can delay clinically appropriate care.

Research from the National Cancer Institute and American Cancer Society indicates that late-stage cancer diagnosis carries heavy financial burdens. For Medicare beneficiaries, cancer-attributable medical costs averaged approximately $45,000 in the first year after diagnosis and nearly $122,000 in the final year of life for those who died from the disease. Early detection remains critical, as survival rates for cancer confined to the breast approach 100% after five years, whereas survival rates drop to 33.8% once the disease has spread to distant parts of the body.